Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Chemotherapy in Treating Patients With Advanced Sarcoma [Phase 2]
This clinical trial update describes a Phase 2 chemotherapy study for patients with advanced sarcoma, with ovarian cancer listed as an addit…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer [EARLY_Phase 1]
This early-phase 1 trial evaluated tumor necrosis factor in patients undergoing surgery for various primary or metastatic cancers, and the s…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating intraperitoneal heated chemotherapy (IPHC) in platinum-sensitive recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission [Phase 2]
This is a Phase 2 trial of vismodegib as maintenance therapy in ovarian cancer patients in second or third complete remission. Results were …
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers [Phase 2]
A Phase 2 trial evaluating weekly docetaxel (Taxotere) in combination with topotecan for recurrent gynecologic cancers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update on EPO906 therapy for advanced ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin [Phase 2]
Phase 2 trial evaluated the combination of lapatinib and topotecan in patients with ovarian cancer or primary peritoneal cancer that did not…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: 11C Topotecan PET Imaging [EARLY_Phase 1]
A EARLY Phase 1 trial of 11C-labeled topotecan for PET imaging in lung and ovarian cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas [Phase 1]
Phase 1 trial evaluating carboxyamidotriazole in combination with paclitaxel for advanced solid tumors and refractory lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: ABT-751 in Treating Young Patients With Refractory Solid Tumors [Phase 1]
A Phase 1 clinical trial of ABT-751 in children with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors [Phase 1]
Phase 1 trial evaluating talabostat in combination with temozolomide or carboplatin in pediatric patients with relapsed or refractory brain …
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy [Phase 1]
Phase 1 pediatric trial update reports initial safety and dosing information for ixabepilone in children with relapsed or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy [Phase 2]
A Phase 2 study evaluating MORAb-003 (farletuzumab) for women with ovarian cancer that relapsed after platinum-based chemotherapy has comple…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
The update reports the completion of a clinical trial evaluating diagnostic imaging of lymph nodes in gynecologic cancers. The study examine…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
Update on the UMCC 003 trial investigating cancer-related protein biomarkers in blood and tumor tissue across several cancers, with the stud…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors [NA]
This completed clinical trial evaluated paclitaxel in combination with CBT-1 for solid tumors, including cervical and ovarian cancers, with …
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 [Phase 1]
This Phase 1 safety and tolerability study of TAK-165 in patients with HER2-expressing tumors has completed, reporting on safety and tolerab…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
A pharmacokinetic study evaluated nadroparin dosing and associated serum HGF levels in gynecologic female patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis [Phase 2, Phase 3]
Clinical trial update on the Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for detecting chemotherapy-induced apoptosis across pha…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer [Phase 2]
Phase 2 study of oral MKC-1 in patients with ovarian or endometrial cancer has completed. The trial was sponsored by CASI Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating tirapazamine plus cisplatin for persistent or recurrent ovarian cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. [EARLY_Phase 1]
A pilot Phase 1 study evaluating whether FDG-PET/CT can predict early chemotherapy response in ovarian cancer; the trial status is completed…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors [Phase 2]
Phase 2 trial evaluating antitumor activity and safety of AEZS-108 in LHRH receptor–positive gynecological tumors (ovarian and endometrial c…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [Phase 2]
This clinical trial update reports results from a Phase 2 study of lymphocyte infusion for patients who relapsed cancer after bone marrow or…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients [Phase 2, Phase 3]
A multicentre Phase 2/Phase 3 trial evaluating Abagovomab as an immunotherapy vaccine for ovarian cancer has been terminated; results were p…